M

Mankind Pharma Ltd
NSE:MANKIND

Watchlist Manager
Mankind Pharma Ltd
NSE:MANKIND
Watchlist
Price: 2 192.2 INR -0.05%
Market Cap: 905B INR

Intrinsic Value

The intrinsic value of one MANKIND stock under the Base Case scenario is 1 814.85 INR. Compared to the current market price of 2 192.2 INR, Mankind Pharma Ltd is Overvalued by 17%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

MANKIND Intrinsic Value
1 814.85 INR
Overvaluation 17%
Intrinsic Value
Price
M
Worst Case
Base Case
Best Case

Valuation History
Mankind Pharma Ltd

What is Valuation History?
Ask AI Assistant
What other research platforms think about MANKIND?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is MANKIND valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Mankind Pharma Ltd.

Explain Valuation
Compare MANKIND to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about MANKIND?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Revenue & Expenses Breakdown
Mankind Pharma Ltd

Balance Sheet Decomposition
Mankind Pharma Ltd

Current Assets 69.9B
Cash & Short-Term Investments 24.9B
Receivables 22.2B
Other Current Assets 22.8B
Non-Current Assets 207.7B
Long-Term Investments 5.3B
PP&E 32.1B
Intangibles 166.2B
Other Non-Current Assets 4.2B
Current Liabilities 56.6B
Accounts Payable 11.3B
Accrued Liabilities 4.6B
Other Current Liabilities 40.7B
Non-Current Liabilities 77.6B
Long-Term Debt 55.4B
Other Non-Current Liabilities 22.2B
Efficiency

Free Cash Flow Analysis
Mankind Pharma Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Mankind Pharma Ltd

Revenue
135.1B INR
Cost of Revenue
-39.2B INR
Gross Profit
95.9B INR
Operating Expenses
-71.8B INR
Operating Income
24.1B INR
Other Expenses
-6.6B INR
Net Income
17.5B INR
Fundamental Scores

MANKIND Profitability Score
Profitability Due Diligence

Mankind Pharma Ltd's profitability score is 57/100. The higher the profitability score, the more profitable the company is.

Positive 3Y Average ROIC
Exceptional Gross Margin
Positive 3Y Average ROE
Strong 3Y Average Gross Margin
57/100
Profitability
Score

Mankind Pharma Ltd's profitability score is 57/100. The higher the profitability score, the more profitable the company is.

MANKIND Solvency Score
Solvency Due Diligence

Mankind Pharma Ltd's solvency score is 62/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Low D/E
Long-Term Solvency
Short-Term Solvency
62/100
Solvency
Score

Mankind Pharma Ltd's solvency score is 62/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

MANKIND Price Targets Summary
Mankind Pharma Ltd

Wall Street analysts forecast MANKIND stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MANKIND is 2 694.98 INR with a low forecast of 2 171.5 INR and a high forecast of 3 423 INR.

Lowest
Price Target
2 171.5 INR
1% Downside
Average
Price Target
2 694.98 INR
23% Upside
Highest
Price Target
3 423 INR
56% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for MANKIND is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one MANKIND stock?

The intrinsic value of one MANKIND stock under the Base Case scenario is 1 814.85 INR.

Is MANKIND stock undervalued or overvalued?

Compared to the current market price of 2 192.2 INR, Mankind Pharma Ltd is Overvalued by 17%.

Back to Top